Stay updated on HOPE-B: AMT-061 Clinical Trial
Sign up to get notified when there's something new on the HOPE-B: AMT-061 Clinical Trial page.

Latest updates to the HOPE-B: AMT-061 Clinical Trial page
- CheckyesterdayChange DetectedVersion metadata updated from v3.3.3 to v3.3.4. No visible study details or content appear to be changed.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe Locations section now lists trial sites across multiple states and countries. Previous location blocks were removed, and the revision is updated to v3.3.3.SummaryDifference1%

- Check36 days agoChange DetectedAdded a new Publications entry: 'Final Analysis of a Study of Etranacogene Dezaparvovec for Hemophilia B. N Engl J Med. 2025 Dec 7. doi: 10.1056/NEJMoa2514332.'SummaryDifference0.0%

- Check52 days agoChange DetectedMinor editorial changes to PubMed-derived publication notices and versioning metadata; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check59 days agoChange DetectedThe government funding status notice banner was removed from the page; there are no changes to the study details, contacts, or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check81 days agoChange DetectedThis page shows only minor administrative updates, including an updated Last Update Posted timestamp and small UI tweaks. There are no changes to eligibility criteria, study design, locations, interventions, or outcome measures. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to HOPE-B: AMT-061 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HOPE-B: AMT-061 Clinical Trial page.